Paola Montes

Effect of 5-Azacitidine Treatment on Redox Status and Inflammatory Condition in MDS Patients

Ana Guerra-Librero, Laura Martínez-Ruiz, D. Acuña-Castroviejo, 2022, Antioxidants.

Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2019, Cancer Immunology, Immunotherapy.

Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients

Javier Martín, F. Garrido, M. Kerick, 2018, Oncotarget.

Effect of 5-Azacitidine Treatment on Redox Status and Inflammatory Condition in MDS Patients

Ana Guerra-Librero, Laura Martínez-Ruiz, D. Acuña-Castroviejo, 2021, Antioxidants.